Clinical Trials Directory

Trials / Unknown

UnknownNCT02158299

Contrast The Role of Avitene And OK-432 in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

Contrast The Role of Microfibrillar Collagen Hemostat Flour(Avitene) And OK-432 (Sapylin)in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
3 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

After Axillary lymphadenectomy for breast cancer there are not few patients showed seroma formation and it can not be ignored.Investigators aimed to study two new methods of application of Microfibrillar Collagen Hemostat Flour and OK-432 to reduce seroma formation and to verify the efficacy and safety of these two applications.Try to prove them as beneficial supplements for axillary lymphadenectomy of breast cancer.

Detailed description

A prospective,randomized analysis of breast-conserving surgery or mastectomy plus axillary lymphadenectomy for those patients with sentinel node positive using Microfibrillar Collagen Hemostat Flour 、 OK-432 or using nothing in equal probability.Up to 12 months,a total of 180 will be recruited in plan.During the operation and after the axillary lymphadenectomy,according the arms,Investigators put Microfibrillar Collagen Hemostat Flour(avitene)、 OK-432(Sapylin) or nothing into patients axillary wounds。And Investigators will the statistical significance of these three arms that the postoperative drainage magnitude and duration.Also the complications associated with axillary lymphadenectomy will be studied.

Conditions

Interventions

TypeNameDescription
DRUGAvitene
DRUGSapylin
BEHAVIORALaxillary drainage
OTHERreexamine

Timeline

Start date
2013-10-01
Primary completion
2014-11-01
First posted
2014-06-06
Last updated
2014-06-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02158299. Inclusion in this directory is not an endorsement.